Healthcare IT & Genomics
Extensive coverage and detailed analysis of healthcare IT and genomics markets. Coverage includes clinical content management IT, imaging IT, archiving & management, digital pathology, advanced visualisation, Ai in drug development, clinical trials, radiation dose management and oncology informatics & diagnostics.
Analyst Insights
How Should Technology Vendors Help Steer the Digital Pathology Revolution?
22nd May 2023 – Digital pathology (DP) adoption is continuing to scale dramatically, with the global market reporting growth of 37.3%, 31.4% and 27.3% over the last three consecutive years. Such growth is, however, relatively new to a market which has been around for decades and only recently started to accelerate in both research and clinical domains.
Signify Premium Insight: Private Equity Firm Sets Sights on Teleradiology
Signify Premium Insights Subscription Required
May 12th 2023 – UK teleradiology firm Medica is set to be acquired by private equity group IK Investment Partners. The move makes sense for the acquirers, with teleradiology a growing market, but what other potential does the deal hold?
Signify Premium Insight: iCAD’s Woes Require More Being Done with Less
Signify Premium Insights Subscription Required
May 9th 2023 – iCAD has recently endured a difficult spell with poor financial results and staff lay-offs. The vendor is looking to rectify the situation with a new CEO. But, is a new leader enough to turn things around?
Signify Premium Insights: AI Generating Headlines at HIMSS 23
Signify Premium Insights Subscription Required
April 27th 2023 – There were many topics to discuss at last week’s HIMSS conference in Chicago. Some, such as generative AI, were particularly headline-grabbing, while others represented new approaches to business as usual. For all of them, however, exhibitors were keen to opine and visitors were keen to listen.
Signify Premium Insight: VC Funding Analysis: When the Big Get Bigger
Signify Premium Insights Subscription Required
April 20th 2023 – As highlighted in Signify Research’s new analysis, VC investors are still willing to back medical imaging AI vendors. However, as this Premium Insight details, the types of vendors, and the regions from which they originate, aren’t so stable.